4-(bis(4-methoxyphenyl)-amino)phenyl-boronic acid (349 mg, 1
mmol). The pure product was separated by a silica gel column
chromatography using CH2Cl2/petroleum ether (2 : 1, v/v) to
yield 320 mg of a red solid (yield 34.8%). Melting point: 204 ꢁC.
1H NMR (CDCl3, 400 MHz), d (TMS, ppm): 0.87–0.92 (m, 6H),
1.28–1.40 (m, 12H), 1.44–1.50 (m, 4H), 1.58–1.65 (m, 4H), 1.89–
2.00 (m, 4H), 3.82 (s, 6H), 4.40–4.49 (m, 4H), 6.85–6.89 (m, 4H),
7.03 (d, J ¼ 8.7 Hz, 2H), 7.11–7.14 (m, 4H), 7.28 (d, J ¼ 9.3 Hz,
1H), 7.44 (d, J ¼ 9.2 Hz, 1H), 7.52 (d, J ¼ 8.7 Hz, 2H), 7.66 (dd,
J1 ¼ 9.2 Hz, J2 ¼ 2.5 Hz, 1H), 7.89 (dd, J1 ¼ 9.0 Hz, J2 ¼ 2.3 Hz,
1H), 8.53 (d, J ¼ 2.5 Hz, 1H), 8.57 (s, 1H), 8.63 (s, 1H), 8.64
(d, J ¼ 2.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz), d (TMS,
ppm): 14.1, 22.7, 27.0, 27.2, 29.3, 29.4, 29.6, 31.8, 55.5, 113.6,
114.8, 116.9, 120.6, 121.2, 124.3, 126.7, 127.2, 131.1, 133.0, 133.5,
133.8, 135.1, 135.5, 137.3, 140.8, 148.0, 156.0, 170.2. HRMS
(ESI, m/z): [M + H]+ calcd for (C56H61N3O4Br): 918.3845; found:
918.3850.
26.1, 27.2, 29.2, 30.6, 45.9, 106.6, 112.5, 113.2, 114.0, 114.2,
117.8, 118.5, 121.8, 124.0, 124.2, 124.5, 125.8, 126.2, 126.5, 126.8,
127.3, 130.4, 131.4, 133.1, 136.0, 138.1, 141.2, 145.6, 150.9, 156.5,
174.3, 175.2. HRMS (ESI, m/z): [M
+
H]+ calcd for
(C61H62N3O4): 900.4740; found: 900.4737.
5-(9-(4-(Bis(4-methoxyphenyl)amino)phenyl)-5,12-dioctyl-7,
14-dioxo-5,7,12,14-tetrahydroquinolino[2,3-b]acridin-2-yl)furan-
2-carbaldehyde (8). The synthesis method resembles that of
compound 6 and the compound was purified by column chro-
matography on silica (CH2Cl2 as eluent) to yield 148 mg of a
1
dark red solid (yield 86.8%). Melting point: 212 ꢁC. H NMR
(CDCl3, 400 MHz), d (TMS, ppm): 0.87–0.94 (m, 6H), 1.30–1.43
(m, 12H), 1.43–1.53 (m, 4H), 1.60–1.69 (m, 4H), 1.95–2.05 (m,
4H), 3.82 (s, 6H), 4.47–4.56 (m, 4H), 6.84–6.91 (m, 5H), 6.99–
7.05 (m, 2H), 7.06–7.15 (m, 4H), 7.33–7.37 (m, 1H), 7.48–7.55
(m, 4H), 7.89 (d, J ¼ 8.0 Hz, 1H), 8.11 (d, J ¼ 8.8 Hz, 1H), 8.64
(s, 1H), 8.67 (s, 1H), 8.71 (s, 1H), 8.80 (s, 1H), 9.64 (s, 1H). 13C
NMR (CDCl3, 100 MHz), d (TMS, ppm): 14.0, 22.7, 26.1, 30.4,
31.6, 32.4, 46.6, 48.8, 105.1, 110.5, 112.9, 113.4, 116.8, 117.5,
117.7, 120.2, 123.4, 123.9, 125.5, 125.7, 125.9, 126.2, 126.9, 129.0,
129.3, 131.8, 132.0, 133.2, 134.6, 140.4, 144.2, 146.9, 148.5, 156.9,
5-(9-(4-(Diphenylamino)phenyl)-5,12-dioctyl-7,14-dioxo-5,7, 12,
14-tetrahydroquinolino[2,3-b]acridin-2-yl)furan-2-carbaldehyde (6).
Compound 3 (257 mg, 0.3 mmol), 2.0 M K2CO3 aqueous solu-
tion (12.5 mL) and a catalytic amount of Pd(PPh3)4 (17 mg, 5 mol
%) in 25 mL THF were heated to reflux for 0.5 h and then
injected with 12.5 mL THF containing 5-formyl-2-furanylbor-
onic acid (84 mg, 0.6 mmol), and the mixture was reacted at
reflux for 12 h. After cooling to room temperature, the mixture
was extracted with 100 mL of CH2Cl2. The organic portion was
combined and removed by rotary evaporation. The residue was
purified by column chromatography on silica (methylene chlo-
ride as eluent) to yield 250 mg of a red solid (yield 95.4%).
175.3, 175.7. HRMS (ESI, m/z): [M
+
H]+ calcd for
(C61H64N3O6): 934.4795; found: 934.4789.
2-Cyano-3-(5-(9-(4-(diphenylamino)phenyl)-5,12-dioctyl-7,14-
dioxo-5,7,12,14-tetrahydroquinolino[2,3-b]acridin-2-yl)furan-2-yl)
acrylic acid (QA1). Compound 6 (140 mg, 0.16 mmol), 2-cya-
noacetic acid (85 mg, 1 mmol) and ammonium acetate (3 mg,
0.039 mmol) in 20 mL acetic acid were heated to reflux under a
nitrogen atmosphere for 12 h. After cooling to room tempera-
ture, the precipitate was filtered and recrystallized with THF/
EtOH to yield 130 mg of a red solid (yield 86.3%). Melting point:
306 ꢁC. 1H NMR (THF-d8, 400 MHz), d (TMS, ppm): 0.80–0.85
(m, 6H), 1.24–1.38 (m, 12H), 1.40–1.50 (m, 4H), 1.51–1.61 (m,
4H), 1.85–1.95 (m, 4H), 4.40–4.50 (m, 4H), 6.88–6.94 (m, 2H),
6.99–7.05 (m, 7H), 7.13–7.18 (m, 4H), 7.24–7.27 (m, 1H), 7.42–
7.46 (m, 2H), 7.50 (d, J ¼ 9.2 Hz, 1H), 7.60 (d, J ¼ 9.2 Hz, 1H),
7.72 (dd, J1 ¼ 9.0 Hz, J2 ¼ 2.1 Hz, 1H), 7.76 (s, 1H), 8.01 (dd, J1
¼ 9.0 Hz, J2 ¼ 1.9 Hz, 1H), 8.36 (s, 1H), 8.40–8.43 (m, 1H), 8.45–
8.48 (m, 2H). 13C NMR (THF-d8, 100 MHz), d (TMS, ppm):
13.5, 22.6, 26.8, 29.4, 31.8, 46.1, 54.0, 61.4, 77.3, 86.8, 91.6, 93.0,
93.9, 103.0, 104.8, 108.7, 113.5, 114.2, 114.6, 120.8, 122.8, 123.9,
124.2, 124.4, 124.7, 125.8, 127.2, 128.3, 132.3, 133.7, 138.5, 142.0,
142.5, 146.1, 147.2, 147.8, 149.6, 158.8, 163.3, 181.2, 182.6, 183.2.
HRMS (ESI, m/z): [M + H]+ calcd for (C62H61N4O5): 941.4642;
found: 941.4644. Anal. calcd for (C62H60N4O5): C 79.12, H 6.43,
N 5.95; found: C 79.01, H 6.34, N 5.88%.
ꢁ
1
Melting point: 213 C. H NMR (CDCl3, 400 MHz), d (TMS,
ppm): 0.90 (t, J ¼ 6.7 Hz, 6H), 1.30–1.44 (m, 12H), 1.45–1.55 (m,
4H), 1.57–1.70 (m, 4H), 1.95–2.06 (m, 4H), 4.48–4.56 (m, 4H),
6.88 (d, J ¼ 3.7 Hz, 1H), 7.06 (t, J ¼ 7.3 Hz, 2H), 7.14–7.19 (m,
6H), 7.27–7.32 (m, 4H), 7.34 (d, J ¼ 3.7 Hz, 1H), 7.50 (t, J ¼ 7.9
Hz, 2H), 7.54–7.57 (m, 2H), 7.88 (dd, J1 ¼ 9.1 Hz, J2 ¼ 2.3 Hz,
1H), 8.08 (dd, J1 ¼ 9.0 Hz, J2 ¼ 2.0 Hz, 1H), 8.62 (s, 1H), 8.67 (d,
J ¼ 2.2 Hz, 1H), 8.68 (s, 1H), 8.77 (d, J ¼ 2.1 Hz, 1H), 9.64 (s,
1H). 13C NMR (CDCl3, 100 MHz), d (TMS, ppm): 14.1, 22.7,
27.1, 29.4, 31.8, 46.9, 107.6, 113.5, 115.2, 115.4, 118.2, 118.3,
121.2, 123.0, 123.8, 124.5, 124.6, 124.7, 126.0, 126.2, 127.3, 129.4,
130.8, 132.9, 135.0, 135.6, 142.3, 147.6, 151.9, 158.5, 177.3, 177.9.
HRMS (ESI, m/z): [M + H]+ calcd for (C59H60N3O4): 874.4584;
found: 874.4579.
(E)-5-(9-(4-(Diphenylamino)styryl)-5,12-dioctyl-7,14-dioxo-5,
7,12,14-tetrahydroquinolino[2,3-b]acridin-2-yl)furan-2-carbalde-
hyde (7). The synthesis method resembles that of compound 6
and the compound was purified by column chromatography on
silica (CH2Cl2 as eluent) to yield 120 mg of a dark red solid (yield
2-Cyano-3-(5-(9-(4-(diphenylamino)styryl)-5,12-dioctyl-7,14-
dioxo-5,7,12,14-tetrahydroquinolino[2,3-b]acridin-2-yl)furan-2-yl)
acrylic acid (QA2). The synthesis method resembles that of
compound QA1 and the compound was recrystallized with THF/
EtOH to yield 99 mg of a dark red solid (yield: 83.8%). Melting
ꢁ
1
86.9%). Melting point: 216 C. H NMR (CDCl3, 400 MHz), d
(TMS, ppm): 0.89–0.95 (m, 6H), 1.30–1.45 (m, 12H), 1.45–1.55
(m, 4H), 1.61–1.70 (m, 4H), 1.91–2.04 (m, 4H), 4.40–4.50 (m,
4H), 6.79–6.81 (m, 1H), 6.94 (d, J ¼ 7.2 Hz, 2H), 7.02–7.08
(m, 4H), 7.14 (d, J ¼ 7.5 Hz, 4H), 7.25–7.32 (m, 5H), 7.32–7.38
(m, 3H), 7.41–7.45 (m, 1H), 7.70 (dd, J1 ¼ 9.1 Hz, J2 ¼ 2.0 Hz,
1H), 7.96 (dd, J1 ¼ 9.0 Hz, J2 ¼ 2.1 Hz, 1H), 8.25 (d, J ¼ 2.0 Hz,
1H), 8.42 (s, 1H), 8.49 (s, 1H), 8.56 (d, J ¼ 2.2 Hz, 1H), 9.59
(s, 1H). 13C NMR (CDCl3, 100 MHz), d (TMS, ppm): 14.0, 22.5,
1
point: 310 ꢁC. H NMR (THF-d8, 400 MHz), d (TMS, ppm):
0.80–0.86 (m, 6H), 1.23–1.37 (m, 12H), 1.39–1.50 (m, 4H), 1.51–
1.59 (m, 4H), 1.86–1.98 (m, 4H), 4.43–4.52 (m, 4H), 6.88–6.94
(m, 4H), 6.96–7.04 (m, 6H), 7.06–7.09 (m, 1H), 7.12–7.17 (m,
4H), 7.28–7.31 (m, 1H), 7.34–7.39 (m, 2H), 7.49 (d, J ¼ 9.0 Hz,
This journal is ª The Royal Society of Chemistry 2012
J. Mater. Chem., 2012, 22, 24356–24365 | 24359